Utah Medical Products Inc 2017 Q4 Institutional Investor Sentiment Better Than Expected

April 20, 2018 - By Marie Mckinney

Sentiment for Utah Medical Products Inc (NASDAQ:UTMD)

Utah Medical Products Inc (NASDAQ:UTMD) institutional sentiment increased to 1.75 in Q4 2017. Its up 0.18, from 1.57 in 2017Q3. The ratio increased, as 42 investment professionals opened new or increased equity positions, while 24 sold and decreased their stock positions in Utah Medical Products Inc. The investment professionals in our partner’s database now possess: 2.40 million shares, down from 2.41 million shares in 2017Q3. Also, the number of investment professionals holding Utah Medical Products Inc in their top 10 equity positions was flat from 0 to 0 for the same number . Sold All: 5 Reduced: 19 Increased: 28 New Position: 14.

Utah Medical Products, Inc. develops, makes, and distributes medical devices for the healthcare industry worldwide. The company has market cap of $396.79 million. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It has a 46.79 P/E ratio. The firm also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit.

The stock decreased 1.21% or $1.3 during the last trading session, reaching $106.5. About 6,849 shares traded. Utah Medical Products, Inc. (NASDAQ:UTMD) has risen 57.70% since April 20, 2017 and is uptrending. It has outperformed by 46.15% the S&P500.

Clean Yield Group holds 1.52% of its portfolio in Utah Medical Products, Inc. for 47,291 shares. Morgan Dempsey Capital Management Llc owns 27,012 shares or 0.71% of their US portfolio. Moreover, Thomson Horstmann & Bryant Inc has 0.47% invested in the company for 43,531 shares. The Illinois-based Ativo Capital Management Llc has invested 0.38% in the stock. Ancora Advisors Llc, a Us-based fund reported 70,358 shares.

Since January 1, 0001, it had 0 insider buys, and 8 selling transactions for $1.56 million activity.

Utah Medical Products, Inc. (NASDAQ:UTMD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.